Skip to content
Screener

Ardelyx ARDX Operating Income

Operating Income at other companies

Amgen logo
AmgenAMGN
$3.51B+32.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$950M-444%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$79.31M+75.0%
AbbVie logo
AbbVieABBV
$6.43B+31.4%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$2.41M+614%
XER
Xeris Biopharma Holdings, Inc.XERS
$5.17M+15.4%

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$1.2B-4.0%
Enterprise value$1.36B-0.6%
P/S2.7×-0.6×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development26,10315,66646,29130,604
Selling, general and administrative101,44083,988203,707167,210
Total costs and operating expenses133,302112,057260,568222,520
Loss from operations(12,425)(14,395)(45,218)(50,744)
Interest expense(4,957)(4,356)(10,556)(8,547)
Non-cash interest expense related to the sale of future royalties(1,267)(2,219)(2,584)(4,290)
Other income, net2,0381,8924,1504,218
Loss before provision for income taxes(16,611)(19,078)(54,208)(59,363)

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's operating income?
Ardelyx (ARDX) reported operating income of -$12.43M in Q2 2026.
How has Ardelyx's operating income changed year-over-year?
Ardelyx's operating income increased by 13.7% year-over-year, from -$14.4M to -$12.43M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Ardelyx's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude